443 related articles for article (PubMed ID: 17867726)
1. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
[TBL] [Abstract][Full Text] [Related]
2. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
3. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database.
de Boissieu P; Kanagaratnam L; Abou Taam M; Roux MP; Dramé M; Trenque T
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):989-92. PubMed ID: 24737486
[TBL] [Abstract][Full Text] [Related]
4. Cataracts and statins. A disproportionality analysis using data from VigiBase.
Macías Saint-Gerons D; Bosco Cortez F; Jiménez López G; Castro JL; Tabarés-Seisdedos R
Regul Toxicol Pharmacol; 2019 Dec; 109():104509. PubMed ID: 31669197
[TBL] [Abstract][Full Text] [Related]
5. Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.
Mendes D; Alves C; Batel-Marques F
J Clin Pharm Ther; 2014 Jun; 39(3):307-13. PubMed ID: 24635532
[TBL] [Abstract][Full Text] [Related]
6. A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.
Salvo F; Leborgne F; Thiessard F; Moore N; Bégaud B; Pariente A
Drug Saf; 2013 Jul; 36(7):565-72. PubMed ID: 23673817
[TBL] [Abstract][Full Text] [Related]
7. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
[TBL] [Abstract][Full Text] [Related]
8. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
9. Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
van Hunsel F; van Puijenbroek E; de Jong-van den Berg L; van Grootheest K
Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):26-32. PubMed ID: 19953500
[TBL] [Abstract][Full Text] [Related]
10. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.
Raschi E; Piccinni C; Poluzzi E; Marchesini G; De Ponti F
Acta Diabetol; 2013 Aug; 50(4):569-77. PubMed ID: 22008948
[TBL] [Abstract][Full Text] [Related]
11. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
12. Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis.
Gravel CA; Krewski D; Mattison DR; Momoli F; Douros A
Br J Clin Pharmacol; 2023 Aug; 89(8):2430-2445. PubMed ID: 36912450
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
14. Existence of Notoriety Bias in FDA Adverse Event Reporting System Database and Its Impact on Signal Strength.
Neha R; Subeesh V; Beulah E; Gouri N; Maheswari E
Hosp Pharm; 2021 Jun; 56(3):152-158. PubMed ID: 34024922
[No Abstract] [Full Text] [Related]
15. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
[TBL] [Abstract][Full Text] [Related]
16. Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.
Ayme-Dietrich E; Kaguelidou F; Bertschy G; Chouchana L
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5814. PubMed ID: 38837561
[TBL] [Abstract][Full Text] [Related]
17. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
Fujimoto M; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced tics: An observational postmarketing study.
Touafchia D; Montastruc F; Lapeyre-Mestre M; Rousseau V; Chebane L; Revet A
Hum Psychopharmacol; 2020 Jul; 35(4):e2734. PubMed ID: 32352603
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
20. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.
Capogrosso Sansone A; Convertino I; Galiulo MT; Salvadori S; Pieroni S; Knezevic T; Mantarro S; Marino A; Hauben M; Blandizzi C; Tuccori M
Drug Saf; 2017 Oct; 40(10):895-909. PubMed ID: 28681266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
